Home›Stock Screener›Granules

Granules Share Price Today | Stock Price & Granules Share Screener

GRANULES Pharmaceuticals & Biotechnology
Live Share Price NSE
₹801.20
▲ 3.70 (0.46%)
2026-11-19 00:00:00
Live Share Price BSE
₹804.40
▲ 6.55 (0.82%)
2026-11-19 00:00:00

As of November 19, 2026, the live Granules share price (NSE: GRANULES) is ₹801.20 on NSE and ₹804.40 on BSE, up 0.46% from the previous close, with shares trading between ₹788.45 and ₹810.50 in today's trading session, and a 52-week range of ₹532.85–₹909.30. Track Granules market cap to gauge the company's total market size. Use the Granules stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Granules opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹1,482 and net income of ₹202, with EBITDA of ₹364, an operating margin of 23.0% and a profit margin of 13.6%.

Granules Market Cap ₹19,797.74 Cr.
GRANULES P/E Ratio (TTM) 31.10
Granules P/B Ratio 3.38
EPS (TTM) ₹24.47
Dividend Yield 0.22%
Debt to Equity 0.34
GRANULES 52 Week High ₹909.30
Granules 52 Week Low ₹532.85
Operating Margin 23.00%
Profit Margin 13.63%
GRANULES Revenue (TTM) ₹1,482.00
EBITDA ₹364.00
Net Income ₹202.00
Total Assets ₹7,720.00
Total Equity ₹5,085.00

Granules Share Price Chart

Track the current stock price of Granules with an interactive chart. Analyse GRANULES share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Granules stock quote in one place.

The quote of ₹801.20 sits between the 52-week low of ₹532.85 and the 52-week high of ₹909.30, and the latest session moved 0.46% from the previous close.

Granules Company Profile - Fundamental Screener

Screen Granules company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GRANULES shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, with C Krishna Prasad listed as chairperson or CEO, and it trades under ISIN INE101D01020.

Business Overview

Granules India Limited is a vertically integrated pharmaceutical company founded in 1991. It manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company specializes in off-patent drugs and first-line defense products like Paracetamol, Ibuprofen, Metformin, and Guaifenesin. Granules India operates seven manufacturing facilities, six in...more

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

Chairperson/CEO C Krishna Prasad
ISIN INE101D01020

Granules Balance Sheet Screener

Screen GRANULES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹7,720, up from ₹6,253 in 2025.

Latest statistics put total assets at ₹7,720 and shareholder funds at ₹5,085, with a leverage ratio of 0.34.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 7,720 6,253 5,521 4,905 4,513 3,714 3,228 2,983 2,677 1,879
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 3,250 2,427 2,096 1,911 1,541 1,332 1,204 944 777 644

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 543 534 213 256 284 367 491 557 495 188
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 5,085 3,716 3,226 2,835 2,587 2,173 1,844 1,530 1,304 904
Share Capital 25 24 24 24 25 25 25 25 25 23
Reserves & Surplus 4,695 3,691 3,201 2,811 2,562 2,149 1,818 1,504 1,279 881

Granules Income Statement Screener - Profit & Revenue Analysis

Screen Granules income statement and profit fundamentals. Analyze GRANULES quarterly results. Granules reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹1,482 and net profit was ₹202, equal to earnings per unit of ₹8.23, at an operating margin of 23%.

In that period expenses were ₹1,119, interest cost ₹33 and tax ₹61. The next period listed, 2026-Jun, shows revenue of ₹1,467 and net profit of ₹180.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 1,482 1,467 1,549 1,230 1,225 1,294 1,374 1,171 1,171 960 1,139 1,199 984 1,190 1,150
Expenses 1,119 1,138 1,222 945 989 1,019 1,080 920 921 763 907 967 849 977 905

Operating Costs and Margins

EBITDA 364 329 327 284 236 275 295 251 251 197 232 232 135 213 245
Operating Profit % 23.00% 22.00% 21.00% 21.00% 18.00% 21.00% 22.00% 21.00% 21.00% 20.00% 20.00% 19.00% 14.00% 18.00% 21.00%
Depreciation 82 80 84 64 69 72 74 53 53 53 57 49 49 53 52
Interest 33 21 21 24 24 29 29 29 27 26 27 19 23 26 29

Profit and Earnings

Profit Before Tax 262 240 243 198 145 176 202 176 181 128 153 164 66 136 170
Tax 61 60 62 46 32 45 52 46 47 31 35 44 18 34 45
Net Profit 202 180 182 152 113 131 150 130 135 97 118 120 48 102 126
EPS 8.23 7.26 7.22 6.27 4.64 5.38 6.19 5.35 5.56 4.01 4.85 4.94 1.98 4.22 5.18

Granules Cash Flow Screener - Liquidity Fundamentals

Screen GRANULES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹793, and net cash flow was an inflow of ₹414.

Over the same period, investing activities used ₹758 and financing activities provided ₹379.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 793 867 439 739 332 433 476 262 -1 188
Investing Activities -758 -689 -358 -192 -379 -277 -160 -270 -462 -326

Financing and Net Cash

Financing Activities 379 -93 8 -440 190 -299 -213 -17 529 56
Net Cash Flow 414 85 90 107 143 -144 103 -25 66 -82

Granules Shareholding Pattern Screener

See Granules shareholding pattern with promoter, FII, and DII holdings. Check Granules promoter holding and ownership changes for GRANULES on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Feb, promoters held 38.02%, foreign institutions 13.79%, domestic institutions 18.51% and the public 19.31%, spread across 163,818 shareholders.

The shareholder count was 163,818 in 2026-Feb, compared with 160,286 in 2026-Mar.

Item 2026-Feb 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec

Promoter Holding

Promoter Holding 38.02% 38.02% 38.02% 37.39% 38.84% 38.82% 38.82% 38.82%

Institutional Investors

FII Holding 13.79% 15.31% 17.50% 20.25% 15.15% 0.00% 14.09% 13.55%
DII Holding 18.51% 17.01% 16.11% 15.33% 22.45% 22.74% 17.92% 17.48%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 19.31% 19.09% 17.85% 17.94% 16.07% 16.54% 18.28% 19.19%
Other Holding 10.38% 10.58% 10.53% 9.10% 7.50% 21.89% 10.89% 10.96%
Shareholder Count 163,818 160,286 169,422 182,080 169,802 169,700 165,542 163,184

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Granules. Granules dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹1.75 per unit for 2026-March, a yield of 0.22%, compared with ₹1.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹1.75, ₹1.50 and ₹1.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹1.75 0.22%
2025-March ₹1.50 0.24%
2024-March ₹1.50 0.31%
2023-March ₹1.50 0.35%
2022-March ₹1.50 0.52%
2021-March ₹1.50 0.49%
2020-March ₹1.00 0.33%
2019-March ₹1.00 0.70%
2018-March ₹1.00 0.87%
2017-March ₹0.90 0.87%

Granules Stock Index Membership - Nifty & Sensex

See which indices include Granules stock. Check GRANULES index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 18 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY 500
NIFTY HEALTHCARE
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

Granules Market Events Screener - Corporate Actions

Get Granules corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Granules stock events that may affect GRANULES share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 2, 2026, with a record date of November 2, 2026.

It is followed by Annual General Meeting dated August 6, 2026 and Dividend dated July 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-02 2026-11-02 Quarterly Result Announcement NA 2.78%
2026-08-06 2026-08-06 Annual General Meeting NA 19.76%
2026-07-30 2026-07-30 Dividend ₹ 1.75 /share 19.40%
2026-07-21 2026-07-21 Quarterly Result Announcement NA 2.10%
2026-04-29 2026-04-29 Quarterly Result Announcement NA 8.03%
2026-01-23 2026-01-23 Quarterly Result Announcement NA -6.49%
2026-01-22 2026-01-22 Extraordinary General Meeting NA -10.66%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -5.09%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -5.97%
2025-08-07 2025-08-07 Annual General Meeting NA -16.92%
2025-07-31 2025-07-31 Dividend ₹ 1.50 /share -6.98%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 18.01%
2025-01-24 2025-01-24 Quarterly Result Announcement NA -2.83%
2024-11-06 2024-11-06 Quarterly Result Announcement NA -9.57%
2024-08-06 2024-08-06 Annual General Meeting NA 60.49%

Granules Competitors Screener - Peer Stocks Comparison

Screen GRANULES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,076 41.10 61,674 12.69% 11,565 59.98
Divis Laboratories 294,139 90.70 11,067 13.95% 2,568 67.88
Torrent Pharmaceuticals 178,438 84.50 13,886 20.34% 2,138 49.31
Laurus Labs 119,949 98.10 6,868 22.01% 890 49.19
Zydus Life Science 118,902 27.60 27,658 17.64% 5,026 52.87
Dr Reddys Laboratories 115,011 41.70 35,059 3.90% 4,158 69.34
Cipla 112,656 39.40 29,045 2.24% 3,870 55.82
Mankind Pharma 108,490 48.40 14,636 14.85% 1,938 63.62
Aurobindo Pharma 103,223 26.40 34,145 5.56% 3,503 60.38
Lupin 90,393 17.30 29,039 26.75% 5,356 44.23

Granules Company Announcements - News & Reports Screener

Screen GRANULES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 14, 2026.

The next most recent announcements are dated November 10, 2026 and November 10, 2026.

Date Update Actions
2026-11-14 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-11-10 Change In Corporate Office Address Of Registrar And Share Transfer Agent -
2026-11-10 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-11-02 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-02 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-02 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-02 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-02 Unaudited Financial Results (Standalone & Consolidated) For The Second Quarter And Half Year Ended On September 30 2026 -
2026-11-02 Board Meeting Outcome for Outcome Of The Board Meeting Dated November 02 2026. -
2026-10-30 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-26 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-24 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-10-24 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-10-24 Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-10-23 Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Second Quarter And Half-Year Ended On September 30 2026 -
2026-10-23 Incorporation Of Wholly Owned Foreign Subsidiary -
2026-10-07 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-06 Transcript Of The Webinar -
2026-10-02 Incorporation Of A Wholly Owned Foreign Subsidiary -
2026-09-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹801.20, within a 52-week range of ₹532.85 to ₹909.30. The P/E ratio is 31.10 and the P/B ratio is 3.38, with earnings per unit of ₹24.47. Market capitalisation stands at ₹19,797.74 Cr and the dividend yield is 0.22%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.